Clinical trial Recruiting at 1 site Interventional Ages 60 and up

Virtual reality training to improve inhibitory control in older adults with cognitive disorders

Official title: Acceptability of a VR-based Training for Inhibitory Control in Subjects With Neurocognitive Disorders

Run by Centre Hospitalier Universitaire de Nice · NCT06597591 · Data updated 2026-11-12

This study tests whether using virtual reality training can help older adults with cognitive disorders improve their self-control skills.

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment48 (estimated)
SponsorCentre Hospitalier Universitaire de Nice
Academic / other
Locations1 site (Nice)
StatusRecruiting
StartedNovember 18, 2024
Main results expectedMay 18, 2027
Study endsNovember 18, 2027
Registry record updatedJune 18, 2026
Trial IDNCT06597591 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are older adults aged 60 and above with a diagnosis of Mild Neurocognitive Disorder or slight Major Neurocognitive Disorder who exhibit deficits in inhibitory control.

Probably not a fit

Patients with significant vision or motor impairments, severe motion sickness, or those classified as vulnerable under French health regulations may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the acceptability of an immersive virtual reality application designed to enhance inhibitory control in older adults diagnosed with neurocognitive disorders. Participants will engage with either a VR headset or a non-immersive tablet version of the application over four weeks, attending sessions twice a week. Throughout the intervention, they will complete questionnaires to assess the acceptability of the training. The goal is to determine how well these innovative tools can support cognitive rehabilitation in this population.

Why it matters

Potential benefit: If successful, this approach could significantly improve cognitive function and quality of life for patients with neurocognitive disorders.

How similar studies have gone: While immersive tools for cognitive training are emerging, this specific application focusing on inhibitory control in neurocognitive disorders is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. consulting the Nice hospital Memory Center
2. diagnosis of Mild Neurocognitve Disorder or slight major neurocognitive disorder (DSM V)
3. 60 years old or more
4. presence of deficits in inhibitory control as assessed by the Frontal Assessment Battery
5. fluent in French
6. able to understand the informed consent form and voluntarily consents to participate

Exclusion Criteria:

1. presence of significant vision or motor problems which would impact ability to perform the task
2. significant self-reported motion sickness
3. vulnerable persons as defined in articles L1121-5 to 8 of the French Public Health Code

Where it's running

  • CHU de Nice
    Nice, France
    Recruiting

Study contacts

  • Principal investigator: Aurélie MOUTON, MD — Centre Hospitalier Universitaire de Nice
  • Study coordinator: Lemaire Justine
  • Email: lemaire.j@chu-nice.fr
  • Phone: +330492034778

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.